Download PDF
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2023; 27(02): e286-e295
DOI: 10.1055/s-0042-1743275
Original Research

Sinonasal Outcomes Using Oral Corticosteroids in Patients with Chronic Rhinosinusitis with Nasal Polyps and Positive Sinonasal Cultures

Jhon F. Martinez-Paredes    #
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, United States
2   Department of Surgery, University of Texas – Rio Grande Valley, Edinburg, Texas, United States
,
Angela M. Donaldson   #
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, United States
,
Michael Marino 
3   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Phoenix, Arizona, United States
,
Garret Choby 
4   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, United States
,
Osarenoma Olomu 
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, United States
,
Razan Alfakir 
5   Department of Speech, Language & Hearing Sciences, Auburn University, Alabama, United States
,
Janalee K. Stokken
4   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, United States
,
Erin O'Brien 
4   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, United States
,
Devyani Lal 
3   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic, Phoenix, Arizona, United States
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Introduction Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and positive sinonasal bacterial cultures may be recalcitrant to topical therapy alone due to the additional local inflammatory burden associated with bacterial infection/colonization.

Objective To evaluate sinonasal outcomes in CRSwNP patients with a positive perioperative bacterial culture, who were treated with postoperative intranasal corticosteroids (INCS) alone versus INCS in combination with a short-term course of oral corticosteroids (OCS).

Methods This is a retrospective chart review of CRSwNP patients. A total of 59 patients met inclusion criteria, including positive perioperative bacterial culture and treatment with INCS with or without concomitant use of OCS. Two cohorts were formed based on the chosen postoperative medical treatment; 32 patients underwent postoperative INCS alone, while 27 underwent INCS plus a ≤ 2-week course of OCS. The 22-item sinonasal outcome test (SNOT-22) scores and Lund-Kennedy scores (LKS) were assessed preoperatively, and at 2-week, 4-week, and 4 to 6 months after endoscopic sinus surgery (ESS).

Results There were no statistically significant differences in postoperative sinonasal symptoms or endoscopic scores between the cohorts treated with INCS plus OCS versus those prescribed INCS alone (p > 0.05). Our regression model failed to demonstrate a relationship between the use of OCS and better sinonasal outcomes at 2-week, 4-week, and 4 to 6 months after ESS (p > 0.05).

Conclusion Our study suggests that in a cohort of CRSwNP patients with recent bacterial infections, the postoperative use of combined OCS and INCS did not result in a statistical improvement of endoscopic and symptomatic outcomes over INCS irrigation alone. However, both treatment groups had a clinically significant improvement based on the Minimal Clinically Important Difference.

Keywords

chronic rhinosinusitis with nasal polyps - corticosteroids - culture - 22-item sinonasal outcome test - endoscopic sinus surgery

# First author co-authorship. Both authors have contributed equally and are listed in increasing order of seniority.




Publication History

Received: 14 May 2021

Accepted: 21 December 2021

Article published online:
19 December 2022

© 2023. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Jervis-Bardy J, Foreman A, Field J, Wormald PJ. Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery. Am J Rhinol Allergy 2009; 23 (05) 549-552
    CrossrefPubMedGoogle Scholar
  • 2 Lee CW, Lee BJ, Yoo SH, Yi JS. Relationship between positive bacterial culture in maxillary sinus and surgical outcomes in chronic rhinosinusitis with nasal polyps. Auris Nasus Larynx 2014; 41 (05) 446-449
    CrossrefPubMedGoogle Scholar
  • 3 Schlosser RJ, Soler ZM. Evidence-based treatment of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2013; 27 (06) 461-466
    CrossrefPubMedGoogle Scholar
  • 4 De Corso E, Baroni S, Lucidi D. et al. Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia. Int Forum Allergy Rhinol 2015; 5 (06) 557-562
    CrossrefPubMedGoogle Scholar
  • 5 Takeda K, Sakakibara S, Yamashita K. et al. Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2019; 143 (03) 1163-1175.e15
    CrossrefPubMedGoogle Scholar
  • 6 Cheng KJ, Zhou ML, Xu YY, Zhou SH. The role of local allergy in the nasal inflammation. Eur Arch Otorhinolaryngol 2017; 274 (09) 3275-3281
    CrossrefPubMedGoogle Scholar
  • 7 Cheng KJ, Wang SQ, Xu YY. Different roles of Staphylococcus aureus enterotoxin in different subtypes of nasal polyps. Exp Ther Med 2017; 13 (01) 321-326
    CrossrefPubMedGoogle Scholar
  • 8 Kennedy JL, Borish L. Chronic sinusitis pathophysiology: the role of allergy. Am J Rhinol Allergy 2013; 27 (05) 367-371
    CrossrefPubMedGoogle Scholar
  • 9 Vickery TW, Ramakrishnan VR, Suh JD. The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis. Curr Allergy Asthma Rep 2019; 19 (04) 1-8
    CrossrefPubMedGoogle Scholar
  • 10 Jervis-Bardy J, Boase S, Psaltis A, Foreman A, Wormald PJ. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope 2012; 122 (10) 2148-2153
    CrossrefPubMedGoogle Scholar
  • 11 Bendouah Z, Barbeau J, Hamad WA, Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006; 134 (06) 991-996
    CrossrefPubMedGoogle Scholar
  • 12 London Jr NR, Lane AP. Innate immunity and chronic rhinosinusitis: What we have learned from animal models. Laryngoscope Investig Otolaryngol 2016; 1 (03) 49-56
    CrossrefPubMedGoogle Scholar
  • 13 Staudacher AG, Stevens WW. Sinus Infections, Inflammation, and Asthma. Immunol Allergy Clin North Am 2019; 39 (03) 403-415
    CrossrefPubMedGoogle Scholar
  • 14 Hox V, Lourijsen E, Jordens A. et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy 2020; 10: 1-27
    CrossrefPubMedGoogle Scholar
  • 15 de Borja Callejas F, Martínez-Antón A, Picado C. et al. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps. Laryngoscope 2015; 125 (05) E158-E167
    CrossrefPubMedGoogle Scholar
  • 16 Howard BE, Lal D. Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis. Curr Allergy Asthma Rep 2013; 13 (02) 236-243
    CrossrefPubMedGoogle Scholar
  • 17 Miyake MM, Bleier BS. Future topical medications in chronic rhinosinusitis. Int Forum Allergy Rhinol 2019; 9 (S1): S32-S46
    CrossrefPubMedGoogle Scholar
  • 18 Donaldson AM, Choby G, Kim DH, Marks LA, Lal D. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults. Otolaryngol Head Neck Surg 2020; 163 (06) 1097-1108
    CrossrefPubMedGoogle Scholar
  • 19 Fandiño M, Macdonald KI, Lee J, Witterick IJ. The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Am J Rhinol Allergy 2013; 27 (05) e146-e157
    CrossrefPubMedGoogle Scholar
  • 20 Banglawala SM, Oyer SL, Lohia S, Psaltis AJ, Soler ZM, Schlosser RJ. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis. Int Forum Allergy Rhinol 2014; 4 (12) 986-994
    CrossrefPubMedGoogle Scholar
  • 21 Xu Z, Luo X, Xu L. et al. Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps. World Allergy Organ J 2020; 13 (06) 100131
    CrossrefPubMedGoogle Scholar
  • 22 Poetker DM, Jakubowski LA, Lal D, Hwang PH, Wright ED, Smith TL. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol 2013; 3 (02) 104-120
    CrossrefPubMedGoogle Scholar
  • 23 Alobid I, Benitez P, Pujols L. et al. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology 2006; 44 (01) 8-13
    PubMedGoogle Scholar
  • 24 Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med 2011; 154 (05) 293-302
    CrossrefPubMedGoogle Scholar
  • 25 Rosenfeld RM, Piccirillo JF, Chandrasekhar SS. et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg 2015; 152 (02, Suppl) S1-S39
    PubMedGoogle Scholar
  • 26 Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009; 34 (05) 447-454
    CrossrefPubMedGoogle Scholar
  • 27 Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997; 117 (3 Pt 2, Supplement) S35-S40
    CrossrefPubMedGoogle Scholar
  • 28 Chowdhury NI, Mace JC, Bodner TE. et al. Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis. Int Forum Allergy Rhinol 2017; 7 (12) 1149-1155
    CrossrefPubMedGoogle Scholar
  • 29 Sedaghat AR. Understanding the Minimal Clinically Important Difference (MCID) of Patient-Reported Outcome Measures. Otolaryngol Head Neck Surg 2019; 161 (04) 551-560
    CrossrefPubMedGoogle Scholar
  • 30 Venekamp RP, Bonten MJM, Rovers MM, Verheij TJM, Sachs APE. Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial. CMAJ 2012; 184 (14) E751-E757
    CrossrefPubMedGoogle Scholar
  • 31 Wang M, Shi P, Chen B, Shi G, Li H, Wang H. Superantigen-induced glucocorticoid insensitivity in the recurrence of chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 2011; 145 (05) 717-722
    CrossrefPubMedGoogle Scholar
  • 32 Van Zele T, Gevaert P, Holtappels G. et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125 (05) 1069-1076.e4
    CrossrefPubMedGoogle Scholar
  • 33 Chesné J, Braza F, Mahay G, Brouard S, Aronica M, Magnan A. IL-17 in severe asthma. Where do we stand?. Am J Respir Crit Care Med 2014; 190 (10) 1094-1101
    CrossrefPubMedGoogle Scholar
  • 34 Wang JJ, Chen CY, Liang KL, Jiang RS. Predictors of nasal bacterial culture rates in patients with chronic rhinosinusitis. Eur J Clin Microbiol Infect Dis 2020; 39 (04) 711-716
    CrossrefPubMedGoogle Scholar
  • 35 Staudacher AG, Peters AT, Kato A, Stevens WW. Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis. Ann Allergy Asthma Immunol 2020; 124 (04) 318-325
    CrossrefPubMedGoogle Scholar
  • 36 Tan BK, Min JY, Hulse KE. Acquired Immunity in Chronic Rhinosinusitis. Curr Allergy Asthma Rep 2017; 17 (07) 1-10
    CrossrefPubMedGoogle Scholar
  • 37 Stevens WW, Peters AT, Tan BK. et al. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract 2019; 7 (08) 2812-2820.e3
    CrossrefPubMedGoogle Scholar
  • 38 Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev 2016; 4: CD011991
    PubMedGoogle Scholar
  • 39 Bülbül T, Bülbül ÖG, Güçlü O, Bilsel AS, Gürsan SÖ. Effect of glucocorticoids on nasal polyposis, with detection of inflammatory response by measurement of nitric oxide levels in nasal polyp tissue. J Laryngol Otol 2013; 127 (06) 584-589
    CrossrefPubMedGoogle Scholar
  • 40 Ho J, Li W, Grayson JW. et al. Systemic medication requirement in post-surgical patients with eosinophilic chronic rhinosinusitis. Rhinology 2021; 59 (01) 59-65
    PubMedGoogle Scholar
  • 41 Orlandi RR, Kingdom TT, Hwang PH. et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol 2016; 6 (Suppl 1) S22-S209
    CrossrefPubMedGoogle Scholar
  • 42 Venekamp RP, Thompson MJ, Hayward G. et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev 2014; (03) CD008115
    PubMedGoogle Scholar
  • 43 Ratau NP, Snyman JR, Swanepoel C. Short-course, low-dose oral betamethasone as an adjunct in the treatment of acute infective sinusitis : a comparative study with placebo. Clin Drug Investig 2004; 24 (10) 577-582
    CrossrefPubMedGoogle Scholar
  • 44 Gehanno P, Beauvillain C, Bobin S. et al. Short therapy with amoxicillin-clavulanate and corticosteroids in acute sinusitis: results of a multicentre study in adults. Scand J Infect Dis 2000; 32 (06) 679-684
    CrossrefPubMedGoogle Scholar
  • 45 Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope 2007; 117 (11 Pt 2, Suppl 115) 1-28
    CrossrefPubMedGoogle Scholar
  • 46 Samter M, Beers Jr RF. Concerning the nature of intolerance to aspirin. J Allergy 1967; 40 (05) 281-293
    CrossrefPubMedGoogle Scholar
  • 47 Samter M, Beers Jr RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68 (05) 975-983
    CrossrefPubMedGoogle Scholar
  • 48 Szczeklik A, Nizankowska E, Duplaga M. AIANE Investigators. European Network on Aspirin-Induced Asthma. Natural history of aspirin-induced asthma. Eur Respir J 2000; 16 (03) 432-436
    CrossrefPubMedGoogle Scholar
  • 49 Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol 2011; 120 (03) 162-166
    CrossrefPubMedGoogle Scholar
  • 50 Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 2006; 6 (03) 161-166
    CrossrefPubMedGoogle Scholar
  • 51 Yoon HY, Lee HS, Kim IH, Hwang SH. Post-operative corticosteroid irrigation for chronic rhinosinusitis after endoscopic sinus surgery: A meta-analysis. Clin Otolaryngol 2018; 43 (02) 525-532
    CrossrefPubMedGoogle Scholar